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Abstract 
Patients presenting with distal weakness can be a diagnostic challenge and the eventual 
diagnosis is often dependent upon accurate clinical phenotyping. We present a case history of 
a mother and daughter with a rare form of distal hereditary motor neuropathy (DHMN) type 7 
in whom the diagnosis was made evident by initial difficulty in singing, due to early vocal 
cord dysfunction. We draw attention to this rare form of neuropathy, which has now been 
identified in two apparently unrelated families in Wales. The clinical presentation of this 
family is typical of DHMN7, and we have identified the common truncating mutation in the 
SLC5A7 gene.  Advances in genetic analysis of these rare conditions broadens our 
understanding of the potential molecular mechanisms and may allow more directed therapy. 
 
  
Case History 
A 52 year old lady (proband) and her 20-year-old daughter had been keen singers, the 
daughter performing with the winning choir at the national Eisteddfod at age 10. At 12-13 
years of age both noticed a change in their voice when singing, the daughter describing the 
change “as if her voice was breaking like a boy’s at puberty”. At age 15, the mother was 
reviewed by an ear nose and throat (ENT) consultant who diagnosed a vocal cord nodule and 
she was referred for speech therapy; however, by age 17, she was re-referred to ENT by her 
music college due to hoarseness of her voice. At that time, she was diagnosed with a benign 
thymic tumor and had a partial thymectomy. Despite this her voice problem progressed with 
deterioration and fatigue more prominent towards the end of the day. A more recent review 
by ENT revealed a persistent glottis chink with poor opposition of vocal cords due to bilateral 
vocal cord paralysis. 
Motor problems in the proband were noticed after her first pregnancy at age 27, at which time 
she struggled with tasks such as doing up her baby’s clothes or making up bottles of milk.  
Motor problems in the daughter were noticed earlier at age 14 with hand cramps especially 
when writing, difficulty with retrieving money from a purse and in using a knife and fork. 
Both have experienced a gradual deterioration in hand function and in addition have noticed 
pain in their feet after walking, cramps in the calf muscles and poor balance. Examination of 
the proband, 50 years after onset, revealed a hoarse voice but otherwise normal cranial 
nerves. She had bilateral severe wasting and weakness of all small hand muscles, more 
prominent at the thenar eminence (fig 1), with retained proximal strength, sensation and 
reflexes. She had high foot arches with clawing of the toes and distal weakness most apparent 
on dorsiflexion, inversion and eversion. Both proband and daughter have retained 
independent mobility. Nerve conduction studies showed normal sensory action potentials and 
sensory and motor conduction velocities with F wave latencies in the normal range. Motor 
action potentials were small and EMG showed changes of distal chronic denervation 
consistent with a motor neuropathy. 
Considering a familial cause of distal motor neuropathy, other members of the family were 
reviewed (fig 2). The proband’s mother had some mild weakness of the first dorsal interossei 
on the right, but no wasting or weakness in the hands. It was noticed that her foot arches were 
high with some clawing of the toes but no weakness. The maternal aunt had relatively high 
arches with toe clawing, but no wasting or weakness. The proband’s father died in 1993 due 
to unrelated causes, but was reported to have had thenar wasting in the right hand which had 
been attributed to a war injury. There were no reported problems in the left hand, feet or 
voice. The clinical phenotype was identified to be consistent with distal hereditary motor 
neuropathy (DHMN) type 7.  The proband had genetic analysis which identified the 
pathogenic c.1497delG mutation in the SLC5A7 gene, which leads to a frameshift mutation 
and premature truncation of the presynaptic choline transporter. Genetic testing was not 
performed in any of the proband’s relatives. 
 
 Discussion 
Differential diagnosis of distal weakness 
When considering distal limb weakness without sensory loss, it is important to establish the 
exact pattern of weakness at disease onset. For example, the typical split hand appearance of 
amyotrophic lateral sclerosis (ALS) with predominant thenar wasting, compared to the 
asymmetric onset of a mononeuritis multiplex. Both conditions characteristically generalise 
to become more symmetric with disease progression. Inclusion body myositis (IBM) and 
myotonic dystrophy (MD) can present with weakness of finger flexion, but are distinguished 
by the pattern of weakness in the lower limbs (predominantly distal calf weakness in MD 
compared to quadriceps weakness in IBM). The pattern is again different in the typical foot 
and finger drop seen in Laing myopathy. 
The next stage is to determine the pathological region of interest, be it spinal cord, nerve or 
muscle (table 1). Information from sensory examination and blood tests (in particular creatine 
kinase), may help point towards a neuropathic, myopathic or dystrophic process. This can be 
aided by extending the physical examination with neurophysiology. Preservation of sensory 
and motor nerve studies is a good indication of normal peripheral nerve function, although 
very proximal conduction block can be missed. Again, a normal EMG from a single muscle 
does not exclude a myopathic process and it is important to ensure thorough 
neurophysiological examination in clinically affected and unaffected muscle groups.  Distal 
chronic denervation with normal sensory studies point to a diagnosis of distal motor 
neuropathy.  Distinguishing myopathies from hereditary motor neuropathy (HMN) is of 
particular importance when discussing prognosis and cardiac screening which is necessary in 
many of the myopathies. 
Distinguishing distal hereditary motor neuropathy types 
DHMN has previously been referred to as spinal CMT, distal spinal muscular atrophy (SMA) 
and as a neuronopathy rather than neuropathy. The confusion in nomenclature relates to the 
uncertainty regarding the site and nature of the major pathogenic lesion. It is becoming 
increasingly understood that different molecular abnormalities can result in diverse 
phenotypes in individuals with a variable degree of involvement of the cell body and axon, 
and that HMN is the most accurate nomenclature for these conditions. 
DHMN is characterised by progressive wasting and weakness in the lower and upper limbs 
without sensory impairment; however, the phenotypic features are variable and have been 
used to define 7 main disease subtypes (table 2). More recently, the number of genes causing 
an HMN phenotype has expanded with increasing recognition of allelic disorders such as 
with the Alanyl-tRNA synthetase (AARs) gene (MIM phenotype number 613287) which can 
cause a phenotype consistent with HMN or CMT2N. There is vast variability in the prognosis 
between HMN types, enhancing the relevance to families of making an accurate diagnosis.  
Distal hereditary motor neuropathy 7 
 Autosomal dominant DHMN with vocal paresis (DHMN7) has been described in two 
families from Wales who were later demonstrated to be related by genealogy1. The typical 
presentation is of a slowly progressive weakness affecting mainly the hands with onset in late 
teens to early twenties. Lower limb involvement is less prominent and mobility is usually 
retained. Voice change can be the presenting feature, but is frequently under reported – unless 
the patient is a keen singer. The family reported here has been followed in the Departments of 
Neurology and Genetics at the University Hospital of Wales and the Royal Gwent Hospital 
from 1994 to 2015. Genetic analysis from affected Welsh families indicated linkage to 
chromosome 2q14 in 20011. Recently, whole exome sequencing has led to the identification 
of a pathogenic frameshift mutation in SLC5A7 in one family, which encodes the presynaptic 
choline transporter involved in synaptic acetylcholine synthesis at the neuromuscular 
junction2.  Although the DHMN with vocal cord paresis phenotype is suggestive of 
DHMN7/SLC5A7 mutation, similar features have been described in patients with TRPV4 
mutations(table 2)3,4.  These families have varying phenotypes including hereditary motor 
and sensory neuropathy 2c5,6, scapuloperoneal SMA7 and congenital non-progressive SMA. 
In some of these families clinical or neurophysiological sensory features can be helpful in 
pointing to a TRPV4 mutation. In patients with prominent upper limb DHMN,clinicians 
should also consider mutations in the BSCL2 and GARS genes (table 2); especially relevant 
in patients who are not keen singers and may have delayed recognition of vocal cord 
problems.   
 
Key points 
1. Precise phenotypic characterisation of distal weakness is essential for guiding 
diagnostic tests 
2. Accurate genetic diagnosis of DHMN types is essential for guiding prognosis. 
3. Advances in genetic understanding of rare disease subtypes will guide development of 
directed therapy. 
4. DHMN7 has a characteristic presentation with vocal cord problems and hand 
weakness. 
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Table 1: Differential diagnosis of distal weakness 
Pathological region Diagnosis  Key notes 
Spine Cervical myelopathy  Always rule out multi-level spinal disease 
Anterior horn cell ALS  Can present with predominantly distal weakness, particularly 
associated with split hand appearance 
Nerve Compressive  If multiple compression palsies, consider HNPP (chromosome 
17p deletion) 
 Metabolic 
Inflammatory 
 
GBS 
In particular uraemic and diabetic related. 
Typical changes on nerve conduction studies confirm peripheral 
nerve involvement 
  MMN 
Vasculitic 
Conduction block on nerve conduction studies. 
Often presenting with mononeuropathies. 
 Inherited CMT For in depth review see Rossor AM et al 8. 
  HMN See table 2 
Muscle Distal myopathy Laing distal myopathy MYH7 (MIM 160500). Prominent weakness in ankle and finger 
extension. 
  Welander distal MD TIA1 (MIM  604454). Commonly presents with upper limb 
weakness first. 
  Nonaka distal myopathy GNE (MIM  605820). Prominent anterior lower leg weakness in 
persons of Japanese descent. 
 Myotonic dystrophy 1  DMPK trinucleotide repeat on chromosome 19 ( Phenotype MIM  
160900). Distal weakness and myotonia 
 FSHMD  Chromosome 4q35 (MIM  158900). Often affects facial muscles 
first, then anterior calf, then scapulohumeral muscles. 
 LGMD 2b: dysferlinopathy / Miyoshi distal MD Dysferlin 2p13.2 (MIM  253601). Prominent posterior calf and 
biceps weakness. Very high CK. 
  1a: myotilin Chromosome 5q31 (MIM  159000). Can also get dysarthria and 
dysphagia and cardiac involvement. 
  2l: anactamin Chromosome 11p14 (MIM  611307). Prominent lower limb 
involvement first. 
 Myofibrillar myopathies Desmin-related: chromosomes 2q35 and 
11q 
Prominent lower limb involvement first with progression to arms 
and respiratory muscles. (MIM  601419) 
 IBM  Weakness of long finger flexors and dysphagia. Typical 
ALS: amyotrophic lateral sclerosis. HNPP: hereditary neuropathy with liability to pressure palsies. GBS: Guillain-Barre syndrome. MMN: 
multifocal motor neuropathy. CMT: Charcot Marie Tooth. HMN: hereditary motor neuropathy. MIM: refers to the MIM phenotype number. 
MD: muscular dystrophy. FSHMD: facioscapulohumeral muscular dystrophy. LGMD: limb girdle muscular dystrophy. IBM: inclusion body 
myositis. 
  
appearance on muscle biopsy. 
 Metabolic Debrancher enzyme deficiency type III Autosomal recessive metabolic disease affecting liver, muscles 
and heart. 
  Phosphorylase b kinase deficiency Glycogen storage disorder type IX affecting liver and muscles 
and causing stress induced hypoglycaemia and ketoacidosis. 
 Nemaline myopathy  Rods on gomori trichrome stain of muscle biopsy 
    
    
 
Table 2: Distal hereditary motor neuropathies 
Type 
MIM 
phenotype no. Inheritance Gene Phenotype 
HMN1 182960 AD Linked to 
7q34-36 
Symmetrical juvenile onset lower limb weakness 
HMN2A 158590 AD HSPB8 Symmetrical progressive lower limb weakness 
HMN2B 608634 AD HSPB1 Symmetrical distal weakness progressing from lower to upper limbs 
HMN2C 613376 AD HSPB3 Symmetrical distal weakness progressing from lower to upper limbs 
HMN2D 615575 AD FBX038 Symmetrical progressive weakness starting distally in calf muscles. 
HMN4 / DSMA3 607088 AR Linked to 
11q13 
Distal weakness with progression to truncal and diaphragmatic weakness 
HMN5A 600794 AD GARS Symmetrical progressive weakness with upper limb predominance. Gene 
defect also causes CMT2D with similar phenotype. 
HMN5A 600794 AD BSCL2 Same phenotype as BSCL2 mutation, but also causes Silver syndrome 
which has an overlapping phenotype with spasticity 
HMN5B 614751 AD REEP1 Weakness predominantly affecting intrinsic hand muscles but also lower 
legs. Overlap with SPG31 (610250) 
HMN6 / SMARD1 604320 AR IGHMBP2 Infantile onset with diaphragm paralysis and respiratory failure. 
SMARD2 / SMAX9  XR LAS1L Infantile onset with diaphragm paralysis and respiratory failure. 
SMAX3 300489 XR ATP7A Distal weakness with prominent gait disorder 
HMN7A 158580 AD SLC5A7 Distal weakness with upper limb predominance and vocal paresis 
HMN7B 607641 AD DCTN1 Distal weakness with upper limb predominance, facial weakness and vocal 
paresis 
Congenital non-progressive 
SMA 
600175 AD TRPV4 Distal lower limb weakness with vocal paresis. Overlapping phenotype 
with SPSMA and CMT2C 
HMN-Jerash type / DSMA2 605726 AR SIGMAR1 Distal weakness with some pyramidal features 
DHMN with pyramidal 
features/ JALS4 
602433 AD SETX Distal weakness with some pyramidal features 
DSMA4 611067 AR PLEKHG5 Distal weakness progressing proximally with associated respiratory failure. 
DSMA5 614881 AR DNAJB2 Symmetrical progressive distal weakness predominantly in lower limbs 
HMN / CMT2N 613287 AD AARS Distal weakness in lower limb. Allelic with Early Infantile Epileptic 
Encephalopathy 29. 
HMN / CMT2 137200 AR HINT1 Distal weakness with little sensory loss. Associated neuromyotonia. 
HMN: hereditary motor neuropathy. AD: autosomal dominant. DSMA: distal spinal muscular atrophy. AR: autosomal recessive. SMARD: spinal muscular 
atrophy with respiratory distress. XR: X- linked recessive. SPSMA: scapuloperoneal spinal muscular atrophy.CMT: Charcot Marie Tooth. SPG spastic 
paraplegia. JALS juvenile amyotrophy lateral sclerosis  
 
 
Figure 1:	Images of the proband demonstratingsevere upper limb wasting apparent in hands, most prominently in the thenar eminence 
bilaterally, with wasting of intrinsic foot muscle but no true pes cavus deformity. 
 
Figure 2: Family history 
 
